N
NAUT
Nautilus Biotechnology Inc
2.950
-0.090-2.96%After Hours: 3.020 +0.070 +2.37%19:15 04/10 EDT
OPEN/PREV CLOSE3.070/3.040
TODAY RANGE2.830-3.175
VOL393.20K
MARKET CAP373.37M
52 WEEK RANGE0.6200-4.310
AVG VOL (3M)282.29K
% TURNOVER0.31%
TURNOVER--
P/E (TTM)-6.3129
% RANGE11.35%
EPS(TTM)-0.4673
P/E(FORWARD)-5.3636
P/B2.377
BVPS1.241
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP210.60M
SHARES OUTSTANDING126.56M
NEXT EARNINGS04/27-05/01
FREE FLOAT71.39M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·2d ago
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
TipRanks·03/18 12:11
Nautilus announces first customer of its Iterative Mapping Early Access Program
TipRanks·03/05 02:15
Top Nautilus Biotechnolgy Insider Quietly Boosts His Stake in a Big Way
Reuters·03/04 23:37
Nautilus Biotechnology CEO Sujal M Patel Acquires Common Shares
TipRanks·03/02 13:31
Nautilus Biotechnology appoints Faust as Vice President of Sales
Reuters·03/02 13:03
Nautilus Biotechnology names Amber Faust vice president of sales
Dow Jones·02/27 15:52
Nautilus Biotechnology Price Target Raised to $4.00/Share From $2.50 by Guggenheim
Dow Jones·02/27 15:52
Nautilus Biotechnology Is Maintained at Buy by Guggenheim
Benzinga·02/27 15:41
Guggenheim Maintains Buy on Nautilus Biotechnology, Raises Price Target to $4
Same Industry